Serum C reactive protein predicts humoral response after BNT162b2 booster administration - 09/06/22
Doi : 10.1016/j.jinf.2022.04.015
Gian Luca Salvagno a, b, Brandon M. Henry c, Laura Pighi a, b, Simone De Nitto a, b, Giuseppe Lippi a, ⁎ 
a Section of Clinical Biochemistry, University of Verona, Verona, Italy
b Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy
c Clinical Laboratory, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
⁎Corresponding author.
Keywords : COVID-19, SARS-CoV-2, Vaccination, Antibodies, C reactive protein
Abbreviations : COVID-19, SARS-CoV-2, IQR
Le texte complet de cet article est disponible en PDF.
Plan
© 2022
Publié par Elsevier Masson SAS.
Vol 85 - N° 1
P. e24-e25 - juillet 2022 Retour au numéro
Article précédent
- Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction
- Yongwen Ren, Lu Lv, Peng Li, Leiliang Zhang
- Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021
- Pragya D. Yadav, Rima R. Sahay, Sachee Agrawal, Anita Shete, Balkrishna Adsul, Srikanth Tripathy, Dimpal A. Nyayanit, Manish Manrai, Deepak Y. Patil, Sanjay Kumar, Vikas Marwah, Gajanan N. Sapkal, Jayanthi Shastri, Rajlakshmi Viswanathan, Priyanka Pandit, Yogendra Mishra, Smita Chavan, Yash Joshi, T Ajai Kumar, Triparna Majumdar, Abhinendra Kumar, Savita Patil, Renuka Munshi, Unnati Desai, Himanshu Kaushal, Annasaheb Suryawanshi, Manisha Dudhmal, Pranita Gawande, Rajlaxmi Jain, Ashwini Waghmare, Kaumudi Kalele, Pratiksha Vedpathak, Jyoti Yemul, Poonam Bodke, Tejashri Kore, A.L. Kakrani, Prachi Athavale, Poonam Suryawanshi, Sudhir Patsute, Vikram Padbidri, Pradip Awate, Priya Abraham
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?